Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Infectious Diseases
Vol. 1, Issue 2, 2013
October 08, 2013 EDT
Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
Emily Durden
,
Donna McMorrow
,
Paul Juneau
,
Robert Fowler
,
Paresh Chaudhari
,
David Horn
,
treatment
costs
burden
economic
aspergillosis
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9862
JHEOR
1.
Durden E, McMorrow D, Juneau P, Fowler R, Chaudhari P, Horn D. Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States.
JHEOR
. 2013;1(2):151-162.
doi:10.36469/9862
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats